T. Rowe Price Associates, Inc. 13D/13G Filings for Cara Therapeutics, Inc. (CARA)

T. Rowe Price Associates, Inc. 13D and 13G filings for Cara Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-16
12:23 pm
Sale		2020-12-3113GCara Therapeutics, Inc.
CARA		T. Rowe Price Associates, Inc.202,436
4.800%		-185,948decrease
(-47.88%)		Filing
2020-02-14
1:30 pm
Sale		2019-12-3113GCara Therapeutics, Inc.
CARA		T. Rowe Price Associates, Inc.388,385
9.900%		-17,099decrease
(-4.22%)		Filing